These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9068960)

  • 21. Observer variation in gynaecological cytopathology.
    O'Sullivan JP
    Cytopathology; 1998 Feb; 9(1):6-14. PubMed ID: 9523123
    [No Abstract]   [Full Text] [Related]  

  • 22. A gridded Pap slide to assure quality with high throughput.
    Sechler GE; Goldsmith S
    Am Clin Lab; 1991 Apr; 10(3):32-3. PubMed ID: 10150102
    [No Abstract]   [Full Text] [Related]  

  • 23. Measuring sensitivity in gynecologic cytology: a review.
    Renshaw AA
    Cancer; 2002 Aug; 96(4):210-7. PubMed ID: 12209662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of specimen adequacy on the diagnosis of ASCUS.
    Sebastião AP; Noronha Ld; Pinheiro DL; Collaço LM; de Carvalho NS; Bleggi-Torres LF
    Diagn Cytopathol; 2004 Sep; 31(3):155-8. PubMed ID: 15349983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Swiss regulation for the specializations of cytopathology and gynecocytology.
    Jenny J
    Recent Results Cancer Res; 1993; 133():145-9. PubMed ID: 8296063
    [No Abstract]   [Full Text] [Related]  

  • 26. Quality control in cytodiagnosis of carcinoma of the cervix.
    Chosia M; Marsan C; Ferrand J; Domagała W
    Pol J Pathol; 2000; 51(2):87-91. PubMed ID: 10974932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability in diagnosis of clue cells, lactobacillary grading and white blood cells in vaginal wet smears with conventional bright light and phase contrast microscopy.
    Donders GG; Larsson PG; Platz-Christensen JJ; Hallén A; van der Meijden W; Wölner-Hanssen P
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):109-12. PubMed ID: 19481329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PAPNET system for quality control of cervical smears: validation and limits.
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receiver operating characteristic curves for analysis of the results of cervicovaginal smears. A useful quality improvement tool.
    Renshaw AA; Dean BR; Cibas ES
    Arch Pathol Lab Med; 1997 Sep; 121(9):968-75. PubMed ID: 9302930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telecytology: intraobserver and interobserver reproducibility in the diagnosis of cervical-vaginal smears.
    Alli PM; Ollayos CW; Thompson LD; Kapadia I; Butler DR; Williams BH; Rosenthal DL; O'leary TJ
    Hum Pathol; 2001 Dec; 32(12):1318-22. PubMed ID: 11774163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experts in Wonderland: in search of the right test and the scientific method.
    Renshaw AA
    Diagn Cytopathol; 2000 Nov; 23(5):297-8. PubMed ID: 11074620
    [No Abstract]   [Full Text] [Related]  

  • 32. An assessment of smear taker training in the Northern & Yorkshire cervical screening programme.
    Faulkner K; Greenwood L; Stamp E
    J Med Screen; 2003; 10(4):201-3. PubMed ID: 14738658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Renshaw A
    Cancer; 2006 Aug; 108(4):267; author reply 268. PubMed ID: 16671112
    [No Abstract]   [Full Text] [Related]  

  • 34. [Development and current status of cytology in Europe].
    Soost HJ
    Med Klin; 1977 Apr; 72(17):769-72. PubMed ID: 853988
    [No Abstract]   [Full Text] [Related]  

  • 35. Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears.
    Arbyn M; Schenck U; Ellison E; Hanselaar A
    Cancer; 2003 Feb; 99(1):9-16. PubMed ID: 12589640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality assurance in cervical cytopathology.
    Llewellyn H
    Cytopathology; 1997 Oct; 8(5):349-50; author reply 353-4. PubMed ID: 9313988
    [No Abstract]   [Full Text] [Related]  

  • 37. Quality assurance in cervical cytopathology.
    Coleman DV; Baker R
    Cytopathology; 1997 Oct; 8(5):350-3; author reply 353-4. PubMed ID: 9313989
    [No Abstract]   [Full Text] [Related]  

  • 38. Public expectations, achievable cervical screening sensitivity, and the standard of practice.
    Austin RM
    Cancer; 2003 Feb; 99(1):1-3. PubMed ID: 12589638
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of monolayer specimens and conventional smears].
    Jensen ML; Fuursted PB; Svanholm H
    Ugeskr Laeger; 2001 Feb; 163(9):1270-5. PubMed ID: 11258251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weekly rescreening of 10% of the total cervical Papanicolaou smears: a worthwhile quality assurance scheme.
    Sampatanukul P; Wannakrairot P; Promprakob U; Yodavudh S; Anansiriprapa C
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S261-5. PubMed ID: 16083199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.